Diagnosing Diabetes Using Amino Acid Profiling of Hair
Profiling amino acids in scalp hair could aid the diagnosis of type 2 diabetes, according to a new study. Researchers performed gas chromatography–mass spectrometry (GC–MS) on hair samples taken from diagnosed patients and healthy patients to show that type 2 diabetes alters the amino acid composition of hair’s main building block, keratin, and that this biomarker could aid diagnosis in the clinic.
Photo Credit: Anthony Lee/Getty Images
Profiling amino acids in scalp hair could aid the diagnosis of type 2 diabetes, according to a new study published in the journal Analytical Chemistry.1 Researchers performed gas chromatography–mass spectrometry (GC–MS) on hair samples taken from diagnosed patients and healthy patients to show that type 2 diabetes alters the amino acid composition of hair’s main building block, keratin, and that this biomarker could aid diagnosis in the clinic.
There are two types of diabetes, type 1 and type 2. Type 1 diabetes usually develops in childhood because of an underproduction of insulin, whereas type 2 diabetes develops because of insulin resistance in later life. According to the paper, because of this insulin resistance, amino acid update by cells is reduced resulting in a variation in freely circulating amino acids available for hair growth. Hair sampling is widely used in forensic investigations because it is noninvasive and hair samples can be stored for longer periods of time than blood or urine. The reason for this is that hair follicles in the scalp source freely circulating amino acids from the bloodstream, therefore newly grown hair reflects changes in these freely circulating amino acids over a period of time. Peter de B. Harrington from the University of Ohio told The Column: “The pilot study2 was an initial investigation if we could use amino acid profiling of hair to identify individuals for forensic investigative leads. From the survey results, we had a large collection of diabetic individuals, so we decided to see if we could identify this disease state from the amino acid profiles in hair.”
To investigate whether scalp hair contained biomarkers, scalp hair samples were taken from 27 people in Jordan - 15 were diagnosed with diabetes mellitus type 2. Hair samples were hydrolyzed using hydrochloric acid followed by amino acid derivatization using N,O-bis(trimethylsilyl)trifluoroacetamide (BSTFA) and subsequently analyzed by GC–MS. The nonessential amino acids Gly, Glu, and Ile were more abundant in the hair of diagnosed patients compared to control subjects.
Harrington told The Column: “There are two key phases for future work: find a faster and gentler method for digesting the hair and freeing the amino acids - we could only reliable observe 14/20, so being able to characterize all 20 would improve the informing power - [and] increase the size of the study so we have more individuals and validate the diabetic condition with blood tests.” - B.D.
References
- A.H.B. Rashaid, P.B. Harrington, and Glen P. Jackson, Analytical Chemistry (2015) DOI: 10.1021/acs.analchem.5b00460
- A.H.B. Rashaid, P.B. Harrington, and Glen P. Jackson, Analytical Methods 7, 1707–1718 (2015).
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
